Bayer AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bayer AG with three other
companies in this sector in UNITED STATES :
sales of $45.80 billion
of which 100%
was pharmaceutical products),
of which 78%
was Innovative Medicines), and
Merck & Co. , Inc.
of which 90%
was Merck Pharmaceutical).
Bayer AG reported sales of $47.50 billion
December of 2020.
decrease of 2.4%
versus 2019, when the company's sales were $48.67 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Bayer AG had sales
of $51.09 billion.
Contributing to the drop in overall sales was the 24.4% decline
in All Other Segments, from $309.62 million to $234.04 million.
There were also decreases in sales in
Cropscience (down 2.5% to $21.61 billion)
Pharmaceuticals and Biological Products (down 1.5% to $19.78 billion)
Consumer Care (down 5.0% to $5.80 billion)
However, these declines were partially offset by the increase in sales of
Reconciliations (up 404.6% to $67.69 million)